Effect of Beta Blockers, Particularly Carvedilol, on Reducing the Risk of Events After Acute Myocardial Infarction

This publication has 42 references indexed in Scilit:

• Carvedilol's antiarrhythmic properties: Therapeutic implications in patients with left ventricular dysfunction
  Clinical Cardiology, 2005
• ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary
  Circulation, 2004
• Reappraisal of β-blocker therapy in the acute and chronic post–myocardial infarction period
  The American Journal of Cardiology, 2004
• Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials
  American Heart Journal, 2003
• Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2)
  Published by Elsevier ,2002
• beta Blockade after myocardial infarction: systematic review and meta regression analysis
  BMJ, 1999
• β-adrenergic blockade in chronic heart failure: Principles, progress, and practice
  Progress in Cardiovascular Diseases, 1998
• Importance of beta blockade in the therapy of serious ventricular arrhythmias
  The American Journal of Cardiology, 1998
• Novel mechanisms in the treatment of heart failure: Inhibition of oxygen radicals and apoptosis by carvedilol
  Progress in Cardiovascular Diseases, 1998
• Beta-adrenergic blockade in the prevention of myocardial infarction: a new theory
  Journal Of Hypertension, 1991